The FY2024 (Dec) proxy of Akebia Therapeutics names 20 peer companies for pay. Among Akebia Therapeutics and these peers, CEO pay was 3rd highest of 4 and total shareholder return was the lowest of 4.
3rd highest of 4in Akebia Therapeutics and its pay peers, FY2024 (Dec) by CEO pay:
$4.1M$7.0M
4th highest of 4in Akebia Therapeutics and its pay peers, FY2024 (Dec) by total shareholder return:
$30$259
Pay peer group, FY2024 (Dec) proxy
| Evolus | ||
| Mirum Pharmaceuticals | ||
| UroGen Pharma | ||
| Ardelyx | Not disclosed | Not disclosed |
| Cara Therapeutics, Inc. | Not disclosed | Not disclosed |
| Coherus BioSciences, Inc. | Not disclosed | Not disclosed |
| Collegium Pharmaceutical | Not disclosed | Not disclosed |
| Eagle Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Enanta Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Intercept Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Karyopharm Therapeutics Inc. | Not disclosed | Not disclosed |
| MacroGenics, Inc. | Not disclosed | Not disclosed |
| Marinus Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Ocular Therapeutix | Not disclosed | Not disclosed |
| OptiNose, Inc. | Not disclosed | Not disclosed |
| Puma Biotechnology, Inc. | Not disclosed | Not disclosed |
| Theravance Biopharma, Inc. | Not disclosed | Not disclosed |
| Vanda Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| Xeris Biopharma Holdings | Not disclosed | Not disclosed |
| Y-mAbs Therapeutics, Inc. | Not disclosed | Not disclosed |
20 companies
Changes by year
FY2025 (Dec) proxy
- AddedEsperion Therapeutics, Inc.pay peer group
- AddedHeron Therapeutics, Inc.pay peer group
- AddedRigel Pharmaceuticals, Inc.pay peer group
- RemovedCara Therapeutics, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedIntercept Pharmaceuticals, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedMirum Pharmaceuticalspay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
FY2024 (Dec) proxy
- AddedCara Therapeutics, Inc.pay peer group
- AddedCoherus BioSciences, Inc.pay peer group
- AddedCollegium Pharmaceuticalpay peer group
- AddedEagle Pharmaceuticals, Inc.pay peer group
- AddedEnanta Pharmaceuticals, Inc.pay peer group
- AddedEvoluspay peer group
- AddedMacroGenics, Inc.pay peer group
- AddedMirum Pharmaceuticalspay peer group
- AddedTheravance Biopharma, Inc.pay peer group
- AddedVanda Pharmaceuticals Inc.pay peer group
- AddedXeris Biopharma Holdingspay peer group
- AddedY-mAbs Therapeutics, Inc.pay peer group
- RemovedAVEO Pharmaceuticals, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedAcorda Therapeutics, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedAlbireo Pharma, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedAytu BioPharma, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedClovis Oncology, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedEvofem Biosciences, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedFortress Biotech, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedKALA BIO, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedOyster Point Pharma, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedParatek Pharmaceuticals, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedRVL Pharmaceuticals plcpay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedTherapeuticsMD, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
FY2023 (Dec) proxy
- AddedAVEO Pharmaceuticals, Inc.pay peer group
- AddedAcorda Therapeutics, Inc.pay peer group
- AddedAlbireo Pharma, Inc.pay peer group
- AddedAytu BioPharma, Inc.pay peer group
- AddedClovis Oncology, Inc.pay peer group
- AddedEvofem Biosciences, Inc.pay peer group
- AddedFortress Biotech, Inc.pay peer group
- AddedKala Pharmaceuticals, Inc.pay peer group
- AddedMarinus Pharmaceuticals, Inc.pay peer group
- AddedOcular Therapeutixpay peer group
- AddedOptiNose, Inc.pay peer group
- AddedOyster Point Pharma, Inc.pay peer group
- AddedParatek Pharmaceuticals, Inc.pay peer group
- RemovedAgios Pharmaceuticalspay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedAmicus Therapeutics, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedAnika Therapeutics, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedCara Therapeutics, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedCollegium Pharmaceuticalpay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedCorcept Therapeuticspay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedEagle Pharmaceuticals, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedEnanta Pharmaceuticals, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedFibroGen, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedIronwood Pharmaceuticals, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedPTC Therapeuticspay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedPacira BioSciencespay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedRadius Health, Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedSupernus Pharmaceuticalspay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedTravere Therapeuticspay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
- RemovedVanda Pharmaceuticals Inc.pay peer groupbecause their market capitalization or operating size moved outside of our targeted range or due to M&A activity
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.